# Annovex Pharma, Inc. – FDA Inspection, Sep 6, 2024

Source: https://www.keypedia.com/records/fda_inspections/annovex-pharma-inc/36ae300a-c916-4ad4-b937-d971e54facb0
Source feed: FDA_Inspections

> FDA inspection 1248991 of Annovex Pharma, Inc., September 06, 2024. Classification: Official Action Indicated (OAI). 7 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1248991
- Company Name: Annovex Pharma, Inc.
- Inspection Date: 2024-09-06
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Baltimore District Office
- Citation Count: 7

## Related Documents

- [FDA Inspection 1321164 - 2026-06-03](https://www.keypedia.com/records/fda_inspections/annovex-pharma-inc/6c5d97b2-604d-4817-85e1-9b4bc3a0471f)

## Related Officers

- [Kara J. Wright](https://www.keypedia.com/people/kara-j-wright/d12b6a4f-9710-4811-b1b2-5ff5f9342155)
- [FDA Associated Person](https://www.keypedia.com/people/tekalign-wondimu/3b80e5c8-4062-4e1d-8ddd-b1afa2616dec)
- [Yaharn Su](https://www.keypedia.com/people/yaharn-su/75b7f7fd-d853-436e-b538-386a8c6df3cb)

Company: https://www.keypedia.com/companies/annovex-pharma-inc/24fc76c5-e88a-4b2d-9d3b-9e6edf3779b0

Office: https://www.keypedia.com/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa